...All right. We're back continuing with the Cowen Liquid Biopsy Summit. It's my pleasure to welcome Kevin Conroy, the Chief Executive Officer and Chairman of Exact Sciences. I think this is a company we all know very well and have a ton of respect for in terms of all that's been accomplished in terms of advancing a new product outside or what was then a new product but an established product that's been really working to improve a real need, which is the number of folks that are confidently screened for colorectal cancer. But beyond Cologuard, Exact Sciences has a really exciting pipeline of new products that they intend to bring to the market over the next several years, many of these in the liquid biopsy space. And we've asked Kevin to come in and talk a bit more about those today. So Kevin, thanks for joining us. We really appreciate it. Let me turn it over to you. Same format as some of the earlier presentations. We'll go through some of your prepared remarks for 10, 15 minutes, whatever...
